ライフサイエンスコーパス: octapeptide

1 peroxynitrite formation in response to this octapeptide.

2 T lymphocytes (CTL) to the fusion partner's octapeptide.

3 a transcription repression domain called the octapeptide.

4 ch contributes to hypertension caused by the octapeptide.

5 ased contractile response to cholecystokinin octapeptide.

6 o generate dose-response curves for the free octapeptide.

7 ion 4 in beta-sheet A of this serpin with an octapeptide.

8 Ki = 0.40 +/- 0.03 microM) than the starting octapeptide.

9 n Pax-B, having both the homeodomain and the octapeptide.

10 contain a paired-type homeodomain and/or an octapeptide.

11 roduct was identified as the SLVELTSL (SEL8) octapeptide.

12 s, ursodeoxycholic acid, and cholecystokinin-octapeptide.

13 rnifin beta contains 21 tandem repeats of an octapeptide.

14 ) supported a model for the synthesis of the octapeptide.

15 bling enabler, we generated a phosphorylated octapeptide.

16 or the lack of contacts normally made by the octapeptide.

17 the self-assembly of lanreotide, a cationic octapeptide.

18 ned with the upstream di-arginine-containing octapeptide.

19 (-1) for a small organic molecule and for an octapeptide.

20 (IC(50) = 2-4 nM) cyclic somatostatin (SRIF) octapeptides.

21 hown to be the case in 18-membered ring SRIF octapeptides.

22 various cancers expressing receptors for SST octapeptides.

23 ins of eight saccharides cross-linked by two octapeptides.

24 et bind to two and only two groups of nRNP A octapeptides.

25 mushrooms in the genus Amanita, are bicyclic octapeptides.

26 ravenous injection of either cholecystokinin octapeptide (200 mug/kg in 0.3 mL saline) or vehicle pla

27 ) selectivity, substitution of Trp(8) in the octapeptide 9 by imBzl-l- or -d-His(8) results in loss o

28 Octapeptide 9 was prepared by de novo synthesis using a

29 e obelin label in a controlled manner to the octapeptide, a fusion protein was produced using recombi

30 In contrast to virus bearing lysine octapeptide, Ad vector displaying a polylysine was capab

31 The 3D NMR structures of six octapeptide agonist analogues of somatostatin (SRIF) in

32 s NMT has been synthesized starting from the octapeptide ALYASKLS-NH2 (2).

33 4 microM) equivalent to that of the starting octapeptide, ALYASKLS-NH2.

34 The cyclic octapeptide amanitin is a relatively selective inhibitor

35 of poisonous Amanita mushrooms are bicyclic octapeptides (amatoxins) or heptapeptides (phallotoxins)

36 The cholecystokinin (26-33) [CCK (26-33)] octapeptide analog Asp-Tyr-D-Phe-Gly-Trp(N-Me)-Nle-Asp-P

37 though a number of synthetic hexapeptide and octapeptide analogs of SRIF bind selectively to SSTR2.

38 ethyl amino acid substitutions in a standard octapeptide analogue format.

39 e-dimensional NMR structures of eight cyclic octapeptide analogues of somatostatin (SRIF) are describ

40 ative L,5D6 antagonist motif on somatostatin octapeptide analogues with a cyclic hexapeptide core.

41 In addition, both lysine octapeptide and polylysine ligands were accessible for b

42 tic secretion in response to cholecystokinin octapeptide and reduced pancreatic digestive enzyme prot

43 as gastrin/carboxy-terminal cholecystokinin octapeptide and selective cholecystokinin antagonists, c

44 ess responsive to vesicular stomatitis virus octapeptide and unresponsive to weak peptide agonists, a

45 Due to the high specificity of the displayed octapeptides and avidity effect of their multicopy displ

46 synthesized a library of over half a million octapeptides and exposed it to light and air in pH 7.4 b

47 ginyl endopeptidase, we prepared a series of octapeptides and mutant legumin B and G4 glycinin subuni

48 -scanning studies with overlapping deca- and octapeptides and polygonal rabbit and human infant immun

49 se activity (using hydrolysis of a synthetic octapeptide), and MMP-8 (using a Western blot) and the b

50 ability of other cyclic hexapeptides, cyclic octapeptides, and a cyclic nonapeptide is also investiga

51 (ELISA) screening against synthesized serial octapeptides, and ELISA screening, with anti-PM-Scl posi

52 Degradation of the biologically potent octapeptide angiotensin Ang II-(1-8) is mediated by the

53 The octapeptide angiotensin II (AII) is proteolytically proc

54 We have shown previously that the octapeptide angiotensin II (Ang II) activates the AT1 re

55 ic forms of ACE both generate the vasoactive octapeptide angiotensin II (Ang II) with equal efficienc

56 eave angiotensin I (Ang I) to the vasoactive octapeptide angiotensin II (Ang II), but is also able to

57 The octapeptide angiotensin II (AngII) exerts a variety of c

58 led compound ((13)C(6)-ochratoxin A), and an octapeptide (angiotensin II).

59 d peptides of increasing size, including the octapeptide, angiotensin II, and the nonapeptide, oxytoc

60 ngiotensin I to produce a potent vasopressor octapeptide, angiotensin II.

61 ntification of novel disulfide-linked cyclic octapeptide antagonists of somatostatin is described.

62 hin the MMTV env gene and was defined by the octapeptide ANYDFICV (AFV8).

63 d potential medical applications of a cyclic octapeptide as the first highly selective small-molecule

64 as solubilized by adding the very polar FLAG octapeptide (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) to the N-t

65 of principle, we have appended an extraneous octapeptide at the N terminus of hepatitis B virus capsi

66 M were matched by incubating DC with cognate octapeptides at 1-10 pM, indicating that display of very

67 predicted to be essential for the binding of octapeptides based on the observation that SSTR1 can bin

68 We showed that cyclic synthetic octapeptides based on the sequence of this loop from Ago

69 Octapeptide binding complements the shape of the combini

70 entarity and greater number of contacts, the octapeptide binds with an affinity (KA = 2.5 x 10(5) M-1

71 After injection of cholecystokinin octapeptide, blood temperature decreased progressively f

72 H-2(b) mice specific for the VSV8 (RGYVYQGL) octapeptide bound to Kb, we identified a single weak ago

73 specific for the vesicular stomatitis virus octapeptide bound to the H-2K(b) molecule were compared

74 s high affinity for sulfated cholecystokinin octapeptide but has > or = 1000-fold lower affinity for

75 B contains a Pax2/5/8-type paired domain and octapeptide, but a Pax6 prd-type homeodomain.

76 The evolved octapeptides, but not first-generation peptides, discrim

77 Removal of the FLAG octapeptide by proteolysis with enterokinase converted t

78 ubicin (AN-201) linked covalently to the SST octapeptide carrier RC-121 (D-Phe-Cys-Tyr-D-Trp-Lys-Val-

79 n applied to the discovery of a new class of octapeptide catalysts for the kinetic resolution of seco

80 The sulfated octapeptide CCK-8S increased action potential frequency

81 for the ability of systemic cholecystokinin octapeptide (CCK) (0 or 10 microg/kg) to inhibit food in

82 Systemic administration of cholecystokinin octapeptide (CCK) slows gastric emptying, inhibits feedi

83 genic mice 5 min after 10 pM cholecystokinin octapeptide (CCK) stimulation was enhanced by 160% of co

84 2 mg/kg, i.p.), and sulfated cholecystokinin octapeptide (CCK-0.05 and 0.1 mg/kg, i.p.) were used to

85 Monoglycated cholecystokinin octapeptide (CCK-8) (glucitol-Asp1 adduct) modified at t

86 cular (i.c.v.) injections of cholecystokinin-octapeptide (CCK-8) and somatostatin (SST) and the inter

87 Cholecystokinin octapeptide (CCK-8) and substance P (SP) were used to ac

88 by a continuous intravenous cholecystokinin octapeptide (CCK-8) infusion was determined by ultrasono

89 The carboxy terminal octapeptide (CCK-8) is fully active in this regard, but

90 prostaglandin E2 (PGE2) and cholecystokinin octapeptide (CCK-8).

91 ts to pancreatitis caused by cholecystokinin octapeptide (CCK-8).

92 P1B3 specifically transports cholecystokinin octapeptide (CCK-8).

93 al injection of low doses of cholecystokinin octapeptide (CCK-8; 10-60 pmol); group B neurones respon

94 he density and distribution of sulphated CCK octapeptide (CCK8S) binding sites and preproCCK peptide

95 n (apo) B17, and various apoB-FLAG (DYKDDDDK octapeptide) chimeras to purified LPL.

96 Then, integrin alpha3beta1-binding octapeptide cNGQGEQc was modified onto ELV platform for

97 Two targeted chromogenic octapeptide combinatorial libraries, comprised of 38 poo

98 Insertion of an octapeptide consisting of the P14-P7 residues of the rea

99 Synthesis of a corresponding octapeptide containing 5 of the 6 interacting residues g

100 le amino acid carriers and to tripeptides or octapeptides containing tyrosine or histidine as central

101 nexpected functional properties of 1 and the octapeptide cyclo(3-14)H-Cys-Phe-Phe-Trp(8)-Lys-Thr-Phe-

102 the PG monomer revealed that the ramoplanin octapeptide D-Hpg-D-Orn-D-alloThr-Hpg-D-Hpg-alloThr-Phe-

103 MSO-d6, 300 K) and molecular modeling of the octapeptide D-Phe1-Cys2-Phe3-D-Trp4-Lys5-Thr6-Cys7+ ++-T

104 An octapeptide derived from RANTES also exhibited neuroprot

105 MC-2, a synthetic octapeptide derived from the heparin-binding domain of m

106 hapten-modified peptides, the immunodominant octapeptide derived from vesicular stomatitis virus nucl

107 TyrBm oxidation of three tyrosine-containing octapeptides derived from glycinin was analyzed by oxyge

108 Among the native partners of PDZ10, octapeptides derived from the hc-kit and 5HT2c proteins

109 entally measured value 10.1 +/- 0.8% for the octapeptide des-Arg(1)-bradykinin.

110 helix with the additional involvement of the octapeptide domain and its N-terminal flanking amino aci

111 riant, c.547G>A (p.Gly183Ser), affecting the octapeptide domain of PAX5 that was found to segregate w

112 e COOH terminus and is down-modulated by the octapeptide element.

113 This octapeptide exerts diverse effects that include inductio

114 The octapeptide exhibits cell compatibility and forms a hydr

115 The two independent molecules of the octapeptide fold into almost ideal beta-hairpin conforma

116 the contractile response to cholecystokinin octapeptide for up to 96 hours after endotoxin administr

117 N15 TCR [1-4] and its peptide-MHC ligand, an octapeptide fragment representing amino acids 52-59 of t

118 Deletion of the N-terminal octapeptide from Mtb's alpha-chain led to disappearance

119 xyphenylalanine, is a potently antimicrobial octapeptide from the blood cells of the solitary tunicat

120 a share binding to eight antigenic groups of octapeptides from nRNP A.

121 und in a patient serum is bound to these two octapeptides from nRNP A.

122 This leader peptidase removes specific octapeptides from the amino terminus of nuclear-encoded

123 mma12 state I since in a shorter gamma-chain octapeptide, GAKQAGDV, gamma12-I is not observed.

124 An octapeptide (GLYASKLS-NH2) derived from a N-terminal Arf

125 a)-methylated aminoglycine (Agl) scan of the octapeptide H-c[Cys(3)-Phe(6)-Phe(7)-dTrp(8)-Lys(9)-Thr(

126 pseudobactins from P. fluorescens A225, the octapeptide has the sequence Chr-Ser(1)-Ala-AcOHOrn-Gly-

127 the lack of the canonical B-chain C-terminal octapeptide, has similar receptor binding affinity to hu

128 A (D-ala(1)-peptide T-amide, a gp120-derived octapeptide homologous to VIP) prevent neuronal cell dea

129 sidues in TM2 of the type 1 receptor for the octapeptide hormone angiotensin II.

130 +) release in response to angiotensin II, an octapeptide hormone that promotes cardiac hypertrophy.

131 Condensation of 10 with octapeptide ILGFVFTL (9) gave prodrug precursor 11b.

132 nous application of sulfated cholecystokinin octapeptide in a reversible and concentration-dependent

133 The amino acid sequence for the octapeptide in case of pseudobactins from P. putida ATCC

134 the contractile response to cholecystokinin octapeptide in gallbladder strips 4 hours after endotoxi

135 support has been used to synthesize tri- to octapeptides in 28 to 97% yields using only 1.2 equiv of

136 rions can be produced following insertion of octapeptides in the two C-terminal turns of H2.

137 MN10021 and derived octapeptides induce iNOS (inducible nitric oxide synthas

138 rdiopulmonary resuscitation, cholecystokinin octapeptide induced mild hypothermia, attenuated postres

139 -free liposomes for 4 hours, cholecystokinin octapeptide-induced contraction, membrane cholesterol co

140 Beginning with a weak octapeptide inhibitor ALYASKLS-NH2 (2, Ki = 15.3 +/- 6.4

141 hamster ovary cells with an immunodetectable octapeptide inserted at their amino-terminal ends.

142 ce express a prion protein (PrP) with a nine-octapeptide insertion associated with a human familial p

143 sed Tg(PG14) mice, which express PrP with an octapeptide insertion associated with an inherited prion

144 olog of a mutant human PrP containing a nine octapeptide insertion associated with prion dementia.

145 ansgenic mice express PrP that harbor a nine-octapeptide insertional mutation homologous to one descr

146 port the development of mini-Ins-a human des-octapeptide insulin analog-as a structurally minimal, fu

147 monstrate that the incorporation of the FLAG octapeptide into the HI loop does not ablate fiber trime

148 d PA225-I, II), the serine(1) residue of the octapeptide is attached to the carboxylic acid group on

149 that, for a range of solid tumours, a cyclic octapeptide labelled with a near-infrared dye selectivel

150 des forming well-defined nanostructures, the octapeptide Lanreotide has been considered one of the be

151 H3K79 methyltransferase, interacts with the octapeptide/leucine zipper domain of AF10, and this regi

152 substrate specificity using tetrapeptide and octapeptide libraries in a positional scanning format, e

153 On-bead screening of an octapeptide library (theoretical diversity of 160 000) i

154 ently revised receptor-bound model for CCK-B octapeptide ligands and are in good agreement with the D

155 eptin docking site was mapped to a divergent octapeptide loop in the AGR2 superfamily between amino a

156 r the suggestion that the Cys-110 to Cys-117 octapeptide loop of human AGRP mimics the conformation o

157 rangement of the disulfide bonds predicts an octapeptide loop, and the chemical properties of four re

158 rotein that contains the naturally processed octapeptide LTFNYRNL (LYL8) presented by the Kb MHC mole

159 An octapeptide (m/z - 902.51, IQKVAGTW) synthesized was fou

160 The octapeptide-mediated repression is also seen within a he

161 e of the pathogen Shigella flexneri Y and an octapeptide (Met-Asp-Trp-Asn-Met-His-Ala-Ala), a functio

162 The octapeptide might be broadly useful for selective tumour

163 We constructed an octapeptide mimicking the omega loop and found that it s

164 ng PEPSCAN each mAb reacted with a number of octapeptides, most of which were derived from within the

165 he homeo-, OAR, and Rx domains, but lacks an octapeptide motif.

166 Here, we rationally designed a high binding octapeptide, N-KSGKSKPR-C peptide for AFB1 detection, by

167 and vesicular stomatitis virus nucleoprotein octapeptide N52-59 relevant for the lymphocytic choriome

168 itioning of ions into a self-assembled (D,L)-octapeptide nanotube, cyclo[-(L-Ala-D-Ala)(4)-], are pre

169 The N-terminus of an octapeptide NAPVSIPQ (NAP) was covalently coupled to a c

170 The central nervous system octapeptide, neuropeptide FF (NPFF), is believed to play

171 The octapeptide-obelin fusion protein retained the biolumine

172 Infusion of a subthreshold dose of the octapeptide of CCK (15 pmol (kg body wt)-1 h-1) potentia

173 nderwent quantitative cholescintigraphy with octapeptide of CCK (CCK-8).

174 9), and its interactions with the C-terminal octapeptide of cholecystokinin (CCK-8) have been determi

175 his study was undertaken to test whether the octapeptide of cholecystokinin (regular CCK-8) and pharm

176 The bimolecular complex of the C-terminal octapeptide of cholecystokinin, CCK-8, with the N-termin

177 The interaction of the C-terminal octapeptide of cholecystokinin, CCK-8, with the third ex

178 d heptapeptide (called CyRP-71) and a linear octapeptide of sequence RRNYRRNY.

179 EBNA-1 and the maximally overlapping unique octapeptides of EBNA-1 were tested by modified ELISAs.

180 receptor C-terminal sequence, as well as for octapeptides of eight other putative partner proteins of

181 uated the binding of lupus autoantibodies to octapeptides of nuclear ribonucleoprotein (nRNP) A, iden

182 sera by solid-phase scanning of overlapping octapeptides of variable domains (VDs) of the major oute

183 predominant that was converted to the final octapeptide only in presence of the appropriate MHC I mo

184 P is observed in the presence of either FLAG octapeptide or bovine serum albumin.

185 th to determine responses to cholecystokinin octapeptide or electrical field stimulation.

186 cted in mice with homozygous deletion of the octapeptide or partial homeodomain, both sequences were

187 monitoring the generation of an OVA-derived octapeptide, OVA257-264 (SL8), and its C-terminally exte

188 portion a nuclear localization signal and an octapeptide (PPPRMPPP) with similarity to a major B cell

189 p beta C8Ala, AspCD2Ala) mutant bound to the octapeptide PQpYEEIPI (where pY indicates a phosphotyros

190 sion in tumour-associated stromal cells, the octapeptide preferentially binds to the invasive edges o

191 molecules that mimic this epsilonPKC agonist octapeptide provide a powerful therapeutic approach to p

192 we describe an epsilonPKC-selective agonist octapeptide, psiepsilon receptor for activated C-kinase

193 ensus epitope via in vitro evolution yielded octapeptides QPEQAFPE and PFPEQxFP that identified omega

194 d in protegrins and tachyplesins whereas the octapeptide R8 (RLYRKVYG) consists of an R4 and a degene

195 to eight copies of a tetrapeptide (R4) or an octapeptide (R8).

196 otoxic hybrid analogs of somatostatin (SST), octapeptides RC-160 (D-Phe-Cys-Tyr-D-Trp- Lys-Val-Cys-Tr

197 is experiments, confirmed the presence of an octapeptide receptor-binding domain toward the amino ter

198 d-type affinity for sulfated cholecystokinin octapeptide, receptors with increasing amino-terminal co

199 178N/V129 variant linked to gCJD and a nine-octapeptide repeat insertion associated with GSS.

200 rion disease caused by a prion protein (PrP) octapeptide repeat insertion mutation originates from so

201 tations P102L, D178N, E200K and 2-, 4- and 6-octapeptide repeat insertions) and show that the glycofo

202 In genetic prion diseases related to octapeptide repeat insertions, the biomarker sensitivity

203 a bacterial gene that encodes a glycine-rich octapeptide repeat protein with distinct variants capabl

204 to bind to the protein in a highly conserved octapeptide repeat region (sequence PHGGGWGQ) near the N

205 Deletion of the octapeptide repeat region did not affect the rescuing ac

206 The copper-binding octapeptide repeat region of PrP was involved in the eff

207 nic strength, confirming that the N-terminal octapeptide repeat region of PrPSc is not required for b

208 Both the KKRPK motif and the octapeptide repeat region of rPrP are essential for maxi

209 ing sites are localized predominantly in the octapeptide repeat region, whereas sites that bind both

210 lly, we explored somatic mosaicism of PRNP's octapeptide repeat region, which is a hypothetical cause

211 containing residues 91-231, which lacks the octapeptide repeat region.

212 ationally masked epitopes in the central and octapeptide repeat regions.

213 ecules expressing 7, 9, and 11 copies of the octapeptide repeat sequence showed altered cell surface

214 rion-related peptides differing in number of octapeptide repeat units (PHGGGWGQ), (PHGGGWGQ)(2), and

215 (IPD) include an insertion of six additional octapeptide repeats (6-OPRI) and a missense mutation (P1

216 on-protein-mediated zinc influx requires the octapeptide repeats and amino-terminal polybasic region

217 other carries an insertion of six additional octapeptide repeats between codons 51 and 90.

218 und that only a mutant containing nine extra octapeptide repeats failed to suppress Bax-induced cell

219 insertion mutant (10OR) with five additional octapeptide repeats linked to familial CJD.

220 res the presence of at least one of the five octapeptide repeats normally present in the N-terminal h

221 oma cells, hamster PrP-sen with 5, 9, and 11 octapeptide repeats were expressed normally on the cell

222 e, hamster PrP molecules with greater than 7 octapeptide repeats were more aggregated and more protea

223 s a mutant prion protein (PrP) containing 14 octapeptide repeats whose human homologue is associated

224 express a pathogenic mutant with nine extra octapeptide repeats, also binds more strongly to GAG tha

225 other insertion mutant, which has five extra octapeptide repeats, rPrP(10OR).

226 uman prion protein that has three additional octapeptide repeats, rPrP(8OR).

227 tion of patients from the UK with four extra octapeptide repeats, which suggest that the risk of clin

228 ich encodes an expanded PrP with eight extra octapeptide repeats.

229 oeba histolytica antigens containing 2 to 16 octapeptide repeats.

230 binding of PTIP to Pax2 is inhibited by the octapeptide repression domain.

231 The linear sequences (through common octapeptide-resin intermediates) were assembled smoothly

232 The vesicular stomatitis virus (VSV) octapeptide RGYVYQGL binds to H-2K(b) and triggers a cyt

233 ted CTLs specific for the immunodominant VSV octapeptide RGYVYQGL.

234 Conjugate 5, which features an octapeptide segment attached by an ester linkage at the

235 In the octapeptide segment IFGSFFTL in IIIS6 of a cockroach sod

236 lving imidazoles from histidines in adjacent octapeptide segments.

237 ngly, the deduced BGAF sequence contained an octapeptide sequence (G(P/R)WGGSGG) repeated twice.

238 We conclude that the octapeptide sequence and neighboring amino acids in the

239 use treatment of patients with peptide T (an octapeptide sequence found in the human immunodeficiency

240 We found that SIAH1 bound to an octapeptide sequence in T-STAR targeting it for proteaso

241 two-residue ay C(12) turn segment in a model octapeptide sequence Leu-Phe-Val-Aib-Xxx-Leu-Phe-Val (wh

242 Mutation or deletion of the conserved octapeptide sequence results in increased transactivatio

243 ) contains four copies of a highly conserved octapeptide sequence, PHGGGWGQ, that is flanked by two p

244 different amino acids in a highly-conserved octapeptide sequence, Z8, located within the region remo

245 predicted to contain two PAAP collagen-like octapeptide sequences.

246 confers a conjugative mating response to an octapeptide sex pheromone (cAD1) secreted by plasmid-fre

247 a mating response induced by exposure to an octapeptide sex pheromone, cAD1, secreted by plasmid-fre

248 The alpha/beta-octapeptides showed the presence of HTH structures with

249 r a series of tripeptides and for two larger octapeptides, showing that the diagnostic phosphate OH s

250 ith the complex of H-2K(b) and the ovalbumin octapeptide SIINFEKL) and peptide-pulsed APCs.

251 65), fused to a polypeptide that contains an octapeptide (SIYRYYGL) agonist for a particular T cell r

252 d on the observation that SSTR1 can bind the octapeptide SMS-201-995 with reasonable affinity after a

253 i-PMScl positive sera did not react with any octapeptide spanning the major epitope area (aa 207-246)

254 on of a mass-labeled leucine monomer from an octapeptide spiked standard was employed as a measure of

255 of 2-pyrrolinodoxorubicin (AN-201) linked to octapeptide SRIF carrier RC-121, may overcome this resis

256 ral CCK receptor agonist CCK8S (sulfated CCK octapeptide) strongly depolarized the neurons, and this

257 CoA analogue [S-(2-oxo)pentadecylCoA] and an octapeptide substrate (GLYASKLA) to 2.5 A resolution.

258 A fluorescence-quenched octapeptide substrate based on the initial hemoglobin cl

259 those functional groups in the high-affinity octapeptide substrate GLYASKLS-NH2 1a necessary for tigh

260 nhibitors of Candida NMT with respect to the octapeptide substrate GNAASARR-NH2 with Ki(app) = 30 and

261 Binding of an octapeptide substrate, representing the N-terminal seque

262 anti-apoptotic effect of MN10021 and derived octapeptides suggesting that their potent vasoprotective

263 Either a hexahistidine or a FLAG octapeptide tag was incorporated into the FAS at either

264 Transframe octapeptide (TFP) Phe-Leu-Arg-Glu-Asp-Leu-Ala-Phe, the N

265 we report the synthesis of Bzim-CP, a cyclic octapeptide that contains a benzimidazole functionality

266 with a paired-type homeobox, as well as the octapeptide that is found in many paired-type homeobox g

267 Argyrins are a family of naturally produced octapeptides that display promising antimicrobial activi

268 In contrast to the peptide agonist CCK octapeptide, the functional activities of the nonpeptide

269 s, respectively; for three isomeric phospho-octapeptides, the accuracy becomes 4.1% and 11% for 17 m

270 s proof-of-concept applications, we used the octapeptide to detect tumour xenografts and metastatic l

271 cently we demonstrated that the fusion of an octapeptide to the C-terminus of a cysteine-free mutant

272 significantly better in the cholecystokinin octapeptide-treated animals when compared to the control

273 Peptide T is an octapeptide under investigation for treatment of ADC pat

274 Octapeptide VDYNFTIV sensitized target cells for lysis b

275 ommon ligand, the vesicular stomatitis virus octapeptide (VSV8) bound to H-2Kb, were studied to defin

276 specific for the vesicular stomatitis virus octapeptide (VSV8) bound to K(b).

277 heat capacity change (DeltaCp) for the 5HT2c octapeptide was determined to be -94 cal/mol, and a calc

278 dder emptying in response to cholecystokinin octapeptide was measured gravimetrically.

279 ximal contraction induced by cholecystokinin octapeptide was significantly less in gallbladders with

280 -to-left synthetic approach to this bicyclic octapeptide was unsuccessful due to an inability to elab

281 ) and several lanthionine hexa-, hepta-, and octapeptides was carried out by using the method of cycl

282 nodoxorubicin (AN-201) linked to SST carrier octapeptide, was investigated in human renal cell carcin

283 sed approach and starting from a linear MLL1 octapeptide, we have designed a class of potent macrocyc

284 te formation induced by the full agonist CCK octapeptide were comparable for the wild-type receptor a

285 n response to 30 and 60 pmol cholecystokinin octapeptide were significantly lower in STZ-D rats compa

286 Pax-B contains both the homeodomain and the octapeptide, whereas hydra Pax-A contains neither.

287 The lanthionine octapeptide with C-terminal Thr-ol (1) showed similar hi

288 Further, conjugation of octapeptide with gold nanoparticles (26 nm) permitted it

289 Similarly, the lanthionine octapeptide with the C-terminal Thr-NH2 residue (2) has

290 The design was partially based on an octapeptide with the same sequence as residues 11-18 abo

291 Moroidin is a bicyclic plant octapeptide with tryptophan side-chain cross-links, orig

292 re the reaction of the antibodies with every octapeptide within MSP-1(42).

293 PLC) analysis of a tryptic digest yielded an octapeptide within the insert of PDE3A ((K)T(806)YNVTDDK

294 The octapeptide WRWYCRCK, containing amino acids from both h